Hematopoietic stem cell transplantation dilemma during the COVID-19 era

Future Oncol. 2020 Aug;16(22):1569-1573. doi: 10.2217/fon-2020-0414. Epub 2020 May 27.

Authors

Ramy Samaha¹, Joseph Kattan¹

Affiliation

¹ Hotel-Dieu de France University Hospital, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon.

No abstract available

Keywords: COVID-19; coronavirus; hematology; hematopoietic stem cell transplantation; oncologist; oncology.

Publication types

Editorial

MeSH terms

Betacoronavirus / immunology*
Betacoronavirus / pathogenicity
COVID-19
Coronavirus Infections / epidemiology
Coronavirus Infections / immunology
Coronavirus Infections / prevention & control*
Coronavirus Infections / virology
Donor Selection / standards
Graft Rejection / immunology
Graft Rejection / prevention & control
Hematopoietic Stem Cell Transplantation / adverse effects
Hematopoietic Stem Cell Transplantation / standards*
Humans
Immunocompromised Host*
Infection Control / standards
Neoplasms / immunology
Neoplasms / therapy*
Pandemics / prevention & control*
Pneumonia, Viral / epidemiology
Pneumonia, Viral / immunology
Pneumonia, Viral / prevention & control*
Pneumonia, Viral / virology
Practice Guidelines as Topic
SARS-CoV-2
Transplantation Conditioning / adverse effects